Ruth Birbe, MD
Departments
Cooper University Health Care Titles
- Co-Director, Cytology
- Pathologist
Cooper Medical School of Rowan University Titles
- Professor of Pathology
Board Certifications
- American Board of Pathology (Anatomic Pathology & Clinical Pathology)
- American Board of Pathology (Cytopathology)
Other Languages
Italian, Spanish
Professional Type
Cooper University Physician
NPI
1184670846
Office Locations
Education & Training
| Medical School | Universidad Central de Venezuela, Caracas, Venezuela |
|---|---|
| Residency | Pathology - Thomas Jefferson University Hospital, Philadelphia, PA |
| Fellowship | Oncologic Pathology - Fox Chase Cancer Center, Philadelphia, PA |
| Fellowship | Cytopathology - Thomas Jefferson University Hospital, Philadelphia, PA |
Special Interests
Oncologic pathology including breast, lung, urologic, gastrointestinal malignancies, and head and neck. Cytopathology with special interest in PAP smears, thyroid, lung, pancreas, and urologic cancer.
Memberships
- United States and Canadian Academy of Pathology
- American Society of Clinical Pathology
- The Pathology Society of Philadelphia (Member and Past President)
- South Jersey Pathology Society
- International Society of Urological Pathology (Member and Panel Expert)
- Pennsylvania Association of Pathologists (Member and Former Executive Council Member)
Awards and Honors
- 2015 PCF Challenge Award for the Proposal Titled "Optimizing First Line Treatment for Men with Castrate Resistant Prostate Cancer" by the Prostate Cancer Foundation.
- 2015 November PCF Challenge Award for the Proposal Titled: "CARAVAN: Checkpoint-Radiation-Vaccine Neoadjuvant Trial for Metastatic Prostate Cancer" by the Prostate Cancer Foundation.
Editorial Positions
2013-2015Journal Specialty Editor The Canadian Journal of Urology
Specialty (Pathology) Editor for the book: The 5 minute Urology Consult by Leonard Gomella, MD. Publisher: LWW; Third edition (December 15, 2014)
Chapter Editor for the book Comprehensive Cytopathology by Marluce Bibbo. Chapter 15, Urinary Tract. Publisher: Saunders; 4 edition (July 21, 2014)
Publications
Complete list at: http://www.ncbi.nlm.nih.gov/sites/myncbi/18GjawZzOxoQn/bibliography/48678652/public/?sort=date&direction=ascending
1: Syed A, Raval A, Pridjian A, Birbe R, Trabulsi EJ. Radiographic Kinetics of Sarcomatoid Renal Cell Carcinoma. Urology. 2016 Mar 31. pii:S0090-4295(16)30007-3. doi: 10.1016/j.urology.2016.03.027. [Epub ahead of print] PubMed PMID: 27041470.
2: Johnson JM, Lai SY, Cotzia P, Cognetti D, Luginbuhl A, Pribitkin EA, Zhan T, Mollaee M, Domingo-Vidal M, Chen Y, Campling B, Bar-Ad V, Birbe R, Tuluc M, Martinez Outschoorn U, Curry J. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. Semin Oncol. 2015 Dec;42(6):915-22. doi:10.1053/j.seminoncol.2015.09.025. Epub 2015 Sep 24. PubMed PMID: 26615136; PubMedCentral PMCID: PMC4663018.
3: Mills TA, Orloff M, Domingo-Vidal M, Cotzia P, Birbe RC, Draganova-Tacheva R, Martinez Cantarin MP, Tuluc M, Martinez-Outschoorn U. Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates. Semin Oncol. 2015 Dec;42(6):909-14. doi: 10.1053/j.seminoncol.2015.09.006. Epub 2015 Sep 8. PubMed PMID: 26615135; PubMed Central PMCID: PMC4663680.
4: Xu SQ, Buraschi S, Morcavallo A, Genua M, Shirao T, Peiper SC, Gomella LG, Birbe R, Belfiore A, Iozzo RV, Morrione A. A novel role for drebrin in regulating progranulin bioactivity in bladder cancer. Oncotarget. 2015 May 10;6(13):10825-39. PubMed PMID: 25839164; PubMed Central PMCID: PMC4484422.
5: Den RB, Feng FY, Showalter TN, Mishra MV, Trabulsi EJ, Lallas CD, Gomella LG, Kelly WK, Birbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1038-46. doi: 10.1016/j.ijrobp.2014.04.052. Epub 2014 Jul 8. PubMed PMID: 25035207; PubMed Central PMCID: PMC4432840.
6: Martinez-Outschoorn UE, Curry JM, Ko YH, Lin Z, Tuluc M, Cognetti D, Birbe RC, Pribitkin E, Bombonati A, Pestell RG, Howell A, Sotgia F, Lisanti MP. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFkB target stromal MCT4. Cell Cycle. 2013 Aug 15;12(16):2580-97. doi: 10.4161/cc.25510. Epub 2013 Jul 8. PubMed PMID: 23860378; PubMed Central PMCID: PMC3865048.
7: Bhavsar T, McCue P, Birbe R. Molecular diagnosis of prostate cancer: are we up to age? Semin Oncol. 2013 Jun;40(3):259-75. doi: 10.1053/j.seminoncol.2013.04.002. Review. PubMed PMID: 23806492.
8: Draganova-Tacheva R, Bibbo M, Birbe R, Daskalakis C, Solomides C. The potential value of phosphohistone-h3 mitotic index determined by digital image analysis in the assessment of pancreatic endocrine tumors in fine-needle aspiration cytology specimens. Acta Cytol. 2013;57(3):291-5. doi: 10.1159/000350885. Epub 2013 Apr 25. PubMed PMID: 23635399.
9: Martinez-Outschoorn UE, Balliet R, Lin Z, Whitaker-Menezes D, Birbe RC, Bombonati A, Pavlides S, Lamb R, Sneddon S, Howell A, Sotgia F, Lisanti MP. BRCA1 mutations drive oxidative stress and glycolysis in the tumor microenvironment: implications for breast cancer prevention with antioxidant therapies. Cell Cycle. 2012 Dec 1;11(23):4402-13. doi: 10.4161/cc.22776. Epub 2012 Nov 21. PubMed PMID: 23172369; PubMed Central PMCID: PMC3552923.
10: Solomides CC, Birbe RC, Nicolaou N, Bagley D, Bibbo M. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks? Acta Cytol. 2012;56(3):285-8. doi: 10.1159/000337649. Epub 2012 Apr 26. PubMed PMID: 22555531.